Literature DB >> 2052570

Isolation of a yeast artificial chromosome spanning the 8;21 translocation breakpoint t(8;21)(q22;q22.3) in acute myelogenous leukemia.

J Gao1, P Erickson, K Gardiner, M M Le Beau, M O Diaz, D Patterson, J D Rowley, H A Drabkin.   

Abstract

The 8;21 translocation is one of the most common specific rearrangements in acute myelogenous leukemia. We have identified markers (D21S65 and a Not I boundary clone, Not-42, referred to as probe B) flanking the chromosome 21 translocation breakpoint (21q22.3) that demonstrate physical linkage in normal genomic DNA, by using at least three restriction endonucleases (Not I, Sac II, and BssHII), and that are located not more than 250-280 kilobases apart. Pulsed-field gel analysis of DNA from somatic cell hybrids containing the 8;21 translocation chromosomes demonstrates rearrangement of these markers. A 470-kilobase yeast artificial chromosome, YAC-Not-42, has been isolated that contains both probes. Mapping of lambda subclones constructed from YAC-Not-42 suggests that greater than 95% (25/26 probes tested) of the yeast artificial chromosome DNA is located on the proximal (D21S65) side of the breakpoint. In situ hybridization studies using metaphase chromosomes from five acute myelogenous leukemia patients with the 8;21 translocation confirmed these results and demonstrated the translocation of probe B to the derivative chromosome 8. A chromosome walk of approximately 39 kilobases from probe B has allowed identification of the breakpoint in DNA from a somatic cell hybrid containing the derivative chromosome 8. Since probe B contains conserved DNA sequences and is in close proximity to the translocation breakpoint, it may represent a portion of the involved gene on chromosome 21.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2052570      PMCID: PMC51771          DOI: 10.1073/pnas.88.11.4882

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  TRANSIENT CONGENITAL LEUKEMIA IN 7 INFANTS WITH MONGOLISM.

Authors:  R R ENGEL; D HAMMOND; D V EITZMAN; H PEARSON; W KRIVIT
Journal:  J Pediatr       Date:  1964-08       Impact factor: 4.406

2.  Comparable complex rearrangements involving 8;21 and 9;22 translocations in leukaemia.

Authors:  V Lindgren; J D Rowley
Journal:  Nature       Date:  1977-04-21       Impact factor: 49.962

3.  Down's syndrome and leukaemia.

Authors:  D I Evans; J K Steward
Journal:  Lancet       Date:  1972-12-16       Impact factor: 79.321

4.  Down Syndrome and acute leukaemia: increased risk may be due to trisomy 21.

Authors:  J D Rowley
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

5.  8;21 translocation in acute granulocytic leukaemia: cytological, cytochemical and clinical features.

Authors:  D M Swirsky; Y S Li; J G Matthews; R J Flemans; J K Rees; F G Hayhoe
Journal:  Br J Haematol       Date:  1984-02       Impact factor: 6.998

6.  Removal of repeated sequences from hybridisation probes.

Authors:  P G Sealey; P A Whittaker; E M Southern
Journal:  Nucleic Acids Res       Date:  1985-03-25       Impact factor: 16.971

7.  Identification of the constant chromosome regions involved in human hematologic malignant disease.

Authors:  J D Rowley
Journal:  Science       Date:  1982-05-14       Impact factor: 47.728

8.  Isolation and analysis of the 21q+ chromosome in the acute myelogenous leukemia 8;21 translocation: evidence that c-mos is not translocated.

Authors:  H A Drabkin; M Diaz; C M Bradley; M M Le Beau; J D Rowley; D Patterson
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

9.  The myeloproliferative reaction in a child with Down syndrome: cytological and chromosomal evidence for a transient leukemia.

Authors:  K H Lazarus; N A Heerema; C G Palmer; R L Baehner
Journal:  Am J Hematol       Date:  1981-12       Impact factor: 10.047

10.  The role of the c-mos gene in the 8;21 translocation in human acute myeloblastic leukemia.

Authors:  M O Diaz; M M Le Beau; J D Rowley; H A Drabkin; D Patterson
Journal:  Science       Date:  1985-08-23       Impact factor: 47.728

View more
  13 in total

Review 1.  Molecular biology in medicine.

Authors:  B D Young
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 2.  AML1-ETO driven acute leukemia: insights into pathogenesis and potential therapeutic approaches.

Authors:  Megan A Hatlen; Lan Wang; Stephen D Nimer
Journal:  Front Med       Date:  2012-08-09       Impact factor: 4.592

3.  Leukaemia: a genetic disorder of haemopoietic cells.

Authors:  L Luzzatto; P P Pandolfi
Journal:  BMJ       Date:  1993-09-04

4.  Partial physical map of human chromosome 21 from fibroblast and lymphocyte DNA.

Authors:  N Crété; J M Delabar; Z Rahmani; M L Yaspo; J Kraus; A Marks; P M Sinet; N Créau-Goldberg
Journal:  Hum Genet       Date:  1993-04       Impact factor: 4.132

5.  YAC clones targeting gene-rich regions of human chromosome 3.

Authors:  R F Williams; Y Pekarsky; S Cheng; K Gardiner
Journal:  Mamm Genome       Date:  1994-06       Impact factor: 2.957

Review 6.  Translocations in epithelial cancers.

Authors:  J Chad Brenner; Arul M Chinnaiyan
Journal:  Biochim Biophys Acta       Date:  2009-05-04

7.  Analysis of chromosome 21 yeast artificial chromosome (YAC) clones.

Authors:  F Tassone; S Cheng; K Gardiner
Journal:  Am J Hum Genet       Date:  1992-12       Impact factor: 11.025

8.  Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions.

Authors:  S Meyers; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

9.  Identification of a yeast artificial chromosome clone encoding an accessory factor for the human interferon gamma receptor: evidence for multiple accessory factors.

Authors:  J Soh; R J Donnelly; T M Mariano; J R Cook; B Schwartz; S Pestka
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

10.  Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing.

Authors:  Li Ding; Timothy J Ley; David E Larson; Christopher A Miller; Daniel C Koboldt; John S Welch; Julie K Ritchey; Margaret A Young; Tamara Lamprecht; Michael D McLellan; Joshua F McMichael; John W Wallis; Charles Lu; Dong Shen; Christopher C Harris; David J Dooling; Robert S Fulton; Lucinda L Fulton; Ken Chen; Heather Schmidt; Joelle Kalicki-Veizer; Vincent J Magrini; Lisa Cook; Sean D McGrath; Tammi L Vickery; Michael C Wendl; Sharon Heath; Mark A Watson; Daniel C Link; Michael H Tomasson; William D Shannon; Jacqueline E Payton; Shashikant Kulkarni; Peter Westervelt; Matthew J Walter; Timothy A Graubert; Elaine R Mardis; Richard K Wilson; John F DiPersio
Journal:  Nature       Date:  2012-01-11       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.